The "Brazil: CBD and Cannabis Regulation 2022" report has been added to ResearchAndMarkets.com's offering.
Despite popular and economic pressure, Brazil hasn't had any substantial changes around medicinal cannabis and hemp legalisation. The Hemp and Medicinal Cannabis Bill that would establish a legal framework for hemp and medicinal cannabis has been stuck in Congress for five years, with almost no development.
The report offers a comprehensive overview of the current regulatory framework in place in Brazil for CBD, hemp and cannabis, covering all areas of law from cultivation and processing to extracts and finished products, as well as the country's medical and recreational regimes.
Key Topics Covered:
- Executive Summary
- Outlook
- Hemp Plant
- Extracts as Finished Products
- Finished Products containing CBD and Extracts
- Import/Export
- Medical Cannabis
- Recreational Cannabis
- Relevant Laws
- Relevant Bodies
For more information about this report visit https://www.researchandmarkets.com/r/s4hk9v
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220421005519/en/
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
